Schedule 13G ownership disclosure

NASUS PHARMA LTD

Ordinary Shares · CUSIP: M7071P109

Event date: 2025-09-30

Filing-level shares
1,901,311.00
Percent of class
21.1%
  • Udi Gilboa

    Shares: 1,901,311.00 · Class: 21.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-021552
Form type
SCHEDULE 13G
Filer
Gilboa Udi
CIK
CIK 1599094
Filed
Nov 10, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub